Cargando…
A133 PORTAL VENOUS STENTING FOR THE TREATMENT OF NON-CIRRHOTIC PORTAL HYPERTENSION-RELATED GASTRIC ANTRAL VASCULAR ECTASIA: A CASE REPORT
BACKGROUND: Pancreatic and hepatobiliary cancers account for 15-24% of extrahepatic portal hypertension. Treating portal hypertensive bleeding associated with these tumors has been challenging with the delayed effect of chemoradiation and patients with active bleeding being unfit for such therapies....
Autores principales: | Deeb, M, Almousawi, F, Annamalai, G, Barragan Leal, C, Wolman, S, Habal, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991377/ http://dx.doi.org/10.1093/jcag/gwac036.133 |
Ejemplares similares
-
Comparison of portal hypertensive gastropathy and gastric antral vascular ectasia: an update
por: Rajabnia, Mohsen, et al.
Publicado: (2022) -
The classification of gastric antral vascular ectasia in cirrhotic patients by Versatile Intelligent Staining Technology
por: Abdelmoneim, Randa Salah Eldin, et al.
Publicado: (2022) -
Accuracy of virtual chromoendoscopy in differentiating gastric antral vascular ectasia from portal hypertensive gastropathy: A proof of concept study
por: Al-Taee, Ahmad M, et al.
Publicado: (2021) -
The misclassification of gastric antral vascular ectasia
por: Aryan, Mahmoud, et al.
Publicado: (2022) -
Gastric Antral Vascular Ectasia in Systemic Sclerosis
por: Johnson, Jill, et al.
Publicado: (2011)